Solventum director exercises 3,403 RSUs

Solventum Corp director Mily Elizabeth exercised restricted stock units into common shares.

Rhea-AI Filing Summary

Solventum Corp director Mily Elizabeth exercised restricted stock units into common shares. On April 30, 2026, 3,403 Restricted Stock Units were converted into 3,403 shares of Solventum common stock at a stated price of $0.00 per share, reflecting a compensation-related equity settlement rather than a market purchase.

Following this exercise, Elizabeth directly held 9,009 shares of Solventum common stock. The RSUs referenced were fully vested and each RSU represented a contingent right to receive one share of common stock upon settlement. The filing shows no open-market sales or tax-withholding dispositions linked to this transaction.

Insider Trade Summary

3,403 shares exercised/converted

Exercise 2 txns

Insider Mily Elizabeth

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	3,403	$0.00	$0.00
Exercise	Common Stock	3,403	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock — 9,009 shares (Direct)

Footnotes (2)

1. F1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
2. F2. The RSUs are fully vested.

Key Figures

RSUs exercised: 3,403 units Common shares acquired: 3,403 shares Shares held after transaction: 9,009 shares +2 more

5 metrics

RSUs exercised 3,403 units Restricted Stock Units converted to common stock on April 30, 2026

Common shares acquired 3,403 shares Common Stock received from RSU settlement

Shares held after transaction 9,009 shares Direct ownership following April 30, 2026 exercise

Exercise price $0.00 per share Recorded transaction and conversion price for RSUs

Derivative expiration date April 30, 2035 Expiration date associated with the RSU award

Key Terms

Restricted Stock Units, derivative security, contingent right, fully vested

4 terms

Restricted Stock Units financial

"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

contingent right financial

"represents a contingent right to receive 1 share of the issuer's Common Stock"

fully vested financial

"The RSUs are fully vested."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Solventum (SOLV) director Mily Elizabeth report in this Form 4 filing?

Mily Elizabeth reported exercising 3,403 Restricted Stock Units into 3,403 shares of Solventum common stock. The RSUs were fully vested, and the transaction reflects equity compensation settlement rather than an open-market stock purchase or sale.

How many Solventum (SOLV) shares does Mily Elizabeth hold after this RSU exercise?

After converting 3,403 Restricted Stock Units into common shares, Mily Elizabeth directly holds 9,009 shares of Solventum common stock. This total represents her direct ownership position following the April 30, 2026 derivative exercise reported in the filing.

Were any Solventum (SOLV) shares sold or withheld for taxes in this Form 4?

The Form 4 does not report any open-market sales or tax-withholding dispositions. It shows an exercise of 3,403 Restricted Stock Units into common stock, with the RSUs fully vesting and converting, and no separate sale or tax-related share disposition recorded.

What are Restricted Stock Units (RSUs) in the context of Solventum (SOLV)?

In this filing, each Restricted Stock Unit represents a contingent right to receive one share of Solventum common stock upon settlement. The RSUs reported were fully vested, meaning the director had satisfied required conditions to receive the underlying shares.

Did Solventum (SOLV) director Mily Elizabeth retain derivative positions after this transaction?

The filing shows 3,403 Restricted Stock Units exercised into common stock, with zero RSUs remaining in that specific award. The derivative summary section is empty, indicating no additional derivative positions are visible in this particular Form 4 excerpt.

What was the exercise price for the Solventum (SOLV) RSUs in this Form 4?

The RSU exercise is recorded with a transaction and conversion price of $0.00 per share. This is typical for RSUs, which generally convert into common stock without a cash payment when vesting and settlement conditions are met by the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mily Elizabeth

(Last) (First) (Middle)

1750 YANKEE DOODLE ROAD

(Street)

EAGAN MINNESOTA 55121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/30/2026		M		3,403	A	$0	9,009	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	04/30/2026		M			3,403	(2)	04/30/2035	Common Stock	3,403	$0	0	D

Explanation of Responses:

1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

2. The RSUs are fully vested.

Remarks:

	/s/Megan Bombick, attorney-in-fact for Elizabeth Mily	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)